New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support ...

Worldwide Clinical Trials has entered into a definitive agreement to acquire Catalyst Clinical Research, a specialized oncology-focused contract research organization (CRO), in a move aimed at ...

Fecal microbiota transplants (FMT) can dramatically improve cancer treatment, suggest two groundbreaking studies published in ...

Global phase 1/2 clinical trial initiated for GBP511, a vaccine targeting the Sarbecovirus Family Next-generation vaccine ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

New sites expected to further accelerate patient enrollment, which surpassed 50% in Phase III study, as well as support future clinical programsGelrinC is set to transform cartilage repair market with ...

Alphamab Oncology (Stock Code: 9966.HK) announced that the results from a phase III clinical study for the treatment of ...

"ICVAX is built on the innovative PD-1-Enhanced DNA vaccine technology invented and developed locally at the HKU," said Professor Zhiwei CHEN. "This study will help optimize delivery of ICVAX, paving ...

Opus Genetics is conducting a trial for OPGx-MERTK gene therapy in Abu Dhabi, targeting MERTK-related retinitis pigmentosa using AAV-based delivery. The trial is a collaboration with Cleveland Clinic ...

Acquisition adds further specialist biostatistics, data management, and medical writing expertise to Evestia Clinical's full-service offering and strengthens its presence in Germany and across Europe ...

When trial participants aren't representative, the evidence for universally adopted cancer treatment guidelines is incomplete ...

In an interview with Targeted Oncology, lead author Brian M. Slomovitz, MD, discusses this move toward a "breast cancer model ...